Technology Arbele has developed proprietary technology platforms to generate new Immunotherapeutics possessing multiple anti-tumor mechanisms for greater efficacy.  Cutting-edge proprietary technologies to address solid tumors: AI-CAR/NK cell therapeutic platform TriAx multipspecific antibody platform  pAC01 single-vector system for trispecific biomanufacturing in CHO cells CA-17 diagnostics (for tissue and liquid biopsies) – companion and POC tests Arbele is harnessing this successful […]

error: Content is protected !!